Christmas came early this year for the FTC, when on July 16 the Third Circuit became the first court to accept the agency’s view that pay-for-delay settlements between patent-holding pharmaceutical companies...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: